Analyst Price Target is GBX 278.33
▼ -1.65% Downside Potential
This price target is based on 3 analysts offering 12 month price targets for Advanced Medical Solutions Group in the last 3 months. The average price target is GBX 278.33, with a high forecast of GBX 300 and a low forecast of GBX 260. The average price target represents a -1.65% upside from the last price of GBX 283.
Current Consensus is
Hold
The current consensus among 3 investment analysts is to hold stock in Advanced Medical Solutions Group. This rating has held steady since August 2026, when it changed from a Moderate Buy consensus rating.
AMS is a world-leading independent developer and manufacturer of innovative tissue-healing technology, focused on quality outcomes for patients and value for payers. AMS has a wide range of surgical products including tissue adhesives, sutures, haemostats, internal fixation devices and internal sealants, which it markets under its brands LiquiBand®, RESORBA®, LiquiBandFix8®, and Seal-G®. AMS also supplies wound care dressings such as silver alginates, alginates and foams through its ActivHeal® brand as well as under white label.
Read More